Chester County News and Community Website
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced promising new data from its IM-PROVE I Phase 2a clinical trial, suggesting significant advancements in treatment for chronic hepatitis B …
Arbutus Biopharma’s Clinical Trial Shows Promise for Hepatitis B Treatment Read More WARMINSTER, PA and OXFORD, United Kingdom — Arbutus Biopharma Corporation and Barinthus Biotherapeutics recently unveiled encouraging preliminary results from their Phase 2a IM-PROVE II clinical trial at the American Association …
Promising New Data from Hepatitis B Trial by Arbutus and Barinthus Read More
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has shared its latest business updates and unaudited financial results for the third quarter ending September 30, 2024. The company is advancing …
Traws Pharma Reports Q3 Financials and Updates on Clinical Advances Read More
NEWTOWN, PA — CenTrak has announced the appointment of Steffi Thorlichen as its new Chief Customer Experience Officer (CXO). With a robust background spanning 25 years in global customer management, …
CenTrak Appoints Steffi Thorlichen as Chief Customer Experience Officer Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a significant leadership change as Craig Fraser steps down from his role as Chief Executive Officer, effective December 1, 2024. …
Leadership Transition at Windtree Therapeutics: Fraser Retires, Latkin Takes Helm Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has reported a remarkable third quarter in 2024, achieving a record revenue of $2.94 million. This represents a 141% increase from the same …
NEXGEL Achieves Record Revenue in Q3 2024 with Promising Growth Outlook Read MoreNEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) this week announced its third quarter financial results for 2024, alongside significant updates on its clinical programs. The company is …
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs Read More
YARDLEY, PA — Optinose (NASDAQ: OPTN) has released its financial results for the third quarter of 2024, revealing an increase in net revenue from its flagship product, XHANCE, and adjustments …
Optinose Reports Q3 2024 Financial Results, Highlights XHANCE Performance Read More
NEWTOWN, PA — EPAM Systems, Inc. (NYSE: EPAM) has announced the release of its StatGPT 2.0 Platform, developed in collaboration with the International Monetary Fund (IMF). This innovative platform aims …
EPAM Systems Unveils StatGPT 2.0 Platform in Collaboration with the IMF Read More NEWTOWN, PA — EPAM Systems, Inc. (NYSE: EPAM) has released its financial results for the third quarter ending September 30, 2024, showcasing steady growth and strategic advancements. The company reported …
EPAM Systems Reports Strong Q3 2024 Financial Performance, Expands Through Strategic Initiatives Read More